Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LLY | JNJ | NVO | MRK | ABBV |
| Company | Eli Lilly and Company | Johnson & Johnson | Novo Nordisk A/S ADR | Merck & Company | Abbvie Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 725.00 | 149.37 | 123.69 | 129.69 | 167.66 |
| High | 727.99 | 149.58 | 125.14 | 132.80 | 169.29 |
| Low | 718.30 | 146.33 | 123.21 | 128.76 | 165.57 |
| Last | 725.04 | 147.00 | 125.32 | 130.97 | 167.35 |
| Change | -7.16 | -1.53 | -0.84 | +3.97 | -0.45 |
| % Change | -0.98% | -1.03% | -0.67% | +3.13% | -0.27% |
| Volume | 1,632,805 | 3,720,351 | 1,781,071 | 6,886,901 | 2,393,173 |
| 20-Day Average Volume | 2,375,029 | 7,834,700 | 3,405,552 | 6,715,827 | 5,113,764 |
| Previous Close | 732.20 | 148.53 | 126.16 | 127.00 | 167.80 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 754.72 | 150.38 | 125.44 | 127.49 | 169.48 |
| 20-Day Raw Stochastic | 10.40% | 22.11% | 37.75% | 72.81% | 33.05% |
| 20-Day Relative Strength | 43.21% | 35.97% | 49.79% | 63.80% | 44.04% |
| Weighted Alpha | +74.46 | -12.07 | +52.51 | +19.60 | +13.07 |
| Today's Opinion | 40% Buy | 100% Sell | 40% Buy | 100% Buy | 24% Buy |
| Previous Opinion | 40% Buy | 100% Sell | 56% Buy | 88% Buy | 40% Buy |
| Last Month's Opinion | 100% Buy | 56% Sell | 88% Buy | 72% Buy | 96% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.66% since 04/18/24 | +0.64% since 04/18/24 | +1.79% since 04/18/24 | +4.24% since 04/18/24 | +1.65% since 04/18/24 |
| Low | 718.30 on 04/25/24 | 144.54 on 04/19/24 | 122.46 on 04/19/24 | 124.89 on 04/19/24 | 163.25 on 04/19/24 |
| High | 752.64 on 04/24/24 | 150.49 on 04/23/24 | 128.76 on 04/23/24 | 132.80 on 04/25/24 | 170.37 on 04/23/24 |
| 1-Month | |||||
| %Chg | -6.08% since 03/25/24 | -5.51% since 03/25/24 | -3.18% since 03/25/24 | +4.18% since 03/25/24 | -6.25% since 03/25/24 |
| Low | 718.30 on 04/25/24 | 143.13 on 04/18/24 | 121.79 on 04/16/24 | 124.50 on 04/18/24 | 160.00 on 04/12/24 |
| High | 793.67 on 03/28/24 | 159.14 on 03/28/24 | 130.16 on 03/28/24 | 133.10 on 03/27/24 | 182.30 on 03/28/24 |
| 3-Month | |||||
| %Chg | +15.70% since 01/25/24 | -8.08% since 01/25/24 | +18.23% since 01/25/24 | +8.67% since 01/25/24 | +1.36% since 01/25/24 |
| Low | 630.50 on 01/26/24 | 143.13 on 04/18/24 | 106.42 on 01/26/24 | 119.23 on 03/15/24 | 160.00 on 04/12/24 |
| High | 800.78 on 03/04/24 | 163.11 on 03/12/24 | 138.28 on 03/07/24 | 133.10 on 03/27/24 | 182.89 on 03/12/24 |
| 6-Month | |||||
| %Chg | +23.82% since 10/25/23 | -3.23% since 10/25/23 | +28.25% since 10/25/23 | +25.97% since 10/25/23 | +15.22% since 10/25/23 |
| Low | 547.61 on 10/31/23 | 143.13 on 04/18/24 | 92.94 on 10/27/23 | 99.80 on 11/29/23 | 135.85 on 11/09/23 |
| High | 800.78 on 03/04/24 | 163.58 on 01/22/24 | 138.28 on 03/07/24 | 133.10 on 03/27/24 | 182.89 on 03/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 695,710,080 | 357,925,056 | 566,147,072 | 321,694,560 | 297,114,560 |
| Shares Outstanding, K | 950,164 | 2,409,783 | 4,487,532 | 2,533,028 | 1,770,647 |
| Annual Sales | 34,124,100,000 | 85,159,000,000 | 33,724,300,000 | 60,115,000,000 | 54,318,000,000 |
| Annual Net Income | 5,240,400,000 | 35,153,000,000 | 12,150,770,000 | 365,000,000 | 4,863,000,000 |
| Last Quarter Sales | 9,353,400,000 | 21,383,000,000 | 9,526,160,000 | 14,631,000,000 | 14,301,000,000 |
| Last Quarter Net Income | 2,189,700,000 | 5,354,000,000 | 3,175,360,000 | -1,226,000,000 | 822,000,000 |
| 60-Month Beta | 0.34 | 0.53 | 0.41 | 0.38 | 0.58 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.49 on 02/06/24 | 2.71 on 04/16/24 | 0.71 on 01/31/24 | 0.03 on 02/01/24 | 2.79 on 02/02/24 |
| Latest Earnings Date | 04/30/24 | 04/16/24 | 05/02/24 | 04/25/24 | 04/26/24 |
| Most Recent Dividend | 1.300 on 02/14/24 | 1.190 on 02/16/24 | 0.663 on 03/22/24 | 0.770 on 03/14/24 | 1.550 on 04/12/24 |
| Next Ex-Dividends Date | 02/14/24 | 05/20/24 | 03/22/24 | 03/14/24 | 04/12/24 |
| Ratios | |||||
| Price/Earnings ttm | 117.99 | 14.30 | 47.56 | 84.59 | 15.26 |